CSL announces $1.5B investment in the U.S. (CSLLY:OTCMKTS)

CSL Limited (OTCQX:CSLLY) (OTCQX:CMXHF), an Australian biotech focused on developing vaccines and blood-derived therapies, on Tuesday announced plans to invest approximately $1.5B in the U.S. over the next five years. The Melbourne-based company said its investments would boost U.S. production of ...